Featured News

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

We know traveling safely is a priority for our celiac disease community. To promote gluten-free vacation options, the Celiac Disease Foundation is pleased to continue our long-standing partnership with Celiac…

The Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, today is proud to announce its newest Board of Directors appointee, Dan Gibbons, who joins the organization this month.

The Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.

The ACeD-it Study is looking for adult volunteers with celiac disease to join a phase 1b/2 clinical trial. Your participation could make a difference.

Want to get involved in celiac disease research? It’s time to take action. The TEV-CeD Study is a phase 1b clinical trial testing the investigational medication TEV-53408 for the treatment of celiac disease.  

New research indicates that a specific set of natural memory T cells, when triggered by gluten, rapidly become destructive and cause intestinal damage in celiac disease patients.

As we look toward the summer months, the team here at the Celiac Disease Foundation is actively working on a number of new projects that are vital to elevating our mission to promote diagnosis, treatments, and a cure for celiac disease.

Congratulations to Celiac Disease Foundation research partner Takeda Pharmaceuticals and its Medical Director Dan Leffler on recent media attention for three potential celiac disease therapies.

This year, we are proud to acknowledge the outpouring of support we received during the month of May.